Launch Diagnostics provides pathology solutions encompassing high quality diagnostic reagents and instrumentation from manufacturers to the Health Services of the United Kingdom, Belgium, Luxembourg, France, and the Republic of Ireland.

Launch Diagnostics

Launch Diagnostics Limited | 1,944 followers on LinkedIn. Launch Diagnostics, part of the Avacta group, provides pathology solutions encompassing high quality diagnostic reagents and instrumentation from world leading manufacturer’s to the Health Services of the United Kingdom, Belgium, Luxemburg, France through Launch Diagnostics SAS, to the Republic of Ireland through ACCUSAY Diagnostics and more recently in Germany with the formation of Launch Diagnostics GmbH.

Offering an extensive portfolio of diagnostic kits and laboratory instrumentation, our product range has expanded over the years to include a comprehensive range of EIA, single test devices, serology products, molecular assays and instrumentation.

Retired

Kay Capaldi

Veronique Petit

Senior Workshop Engineer at Launch Diagnostics Ltd

Gary Hood

Product Specialist at Launch Diagnostics and volunteer for the KSS Neonatal Parent Advisory Group

Lisa O’Hara

Launch Diagnostics Limited

It’s National Pathology Week! This week celebrates the essential role of the Pathology service. These medical detectives work behind the scenes, diagnosing diseases through lab tests, guiding treatment decisions, and contributing to a vast number of patient diagnoses. Their expertise in analysing a range of different samples is vital for patient care, research, and public health, making their role crucial in the fight against illnesses. https://lnkd.in/djC7y4pZ

Launch Diagnostics Ltd is pleased to add the Myra instrument from Biomolecular Systems to our molecular diagnostics repertoire for PCR setup! The Myra is designed to optimise PCR workflows by combining advanced motion control and precision pipetting with effortless automation. - Precision Pipetting & Motion Control: Engineered specifically for PCR, the Myra ensures accuracy and consistency with minimal hands on time. - Integrated Camera Calibration: Calibrate plasticware with a single click. - Seamless Cycler Integration: Integration & runfile export to PCR cyclers eliminates manual data transfers, with associated error reduction. - Contamination Prevention: UV LED on the pipetting head, replaceable HEPA filter, and closed waste container for secure, contamination-free setups. - Small Footprint: Compact, multifunctional configuration maximises lab space. Paired with Launch Diagnostics’ wide range of PCR assays, Myra allows for expansion or streamlining of PCR repertoires without requiring additional staff or large equipment. To learn more please visit the website or speak to your local Territory Manager. #PCR #LiquidHandling #LaboratoryAutomation #Diagnostics #Biotech https://lnkd.in/e9d5zmAX

Gold Standard Diagnostics’ AIX 1000 distributed by Launch Diagnostics, is a fully automated RPR testing instrument for non-treponemal syphilis confirmation. It produces up to 192 screening or titration results in 90 minutes, reducing hands on time, with quicker turn-around times, in comparison to manual methods. The onboard camera with pattern recognition and a user-friendly software ensures standardised, objective interpretation. Results are archived and all images can be accessed for reviewing & training purposes. For further information, please visit https://lnkd.in/eD-Ta2wK Or contact your local Territory manager #goldstandarddiagnostics #launchdiagnostics #syphilis #RPR

The BioCLIA 6500 and BioCLIA 500 provide ideal automation for any Immunology lab - big or small. Continuous loading of all reagents and consumables means no need to plan your whole day - just start running and add as you go! Along with random access, fast throughput, on-board reagent storage, and easy maintenance it’s easy to see why these instruments are proving so popular. Combining these features with a comprehensive autoimmune test repertoire and you have everything the busy lab needs. Contact your local Launch representative or go to our website for further information. https://lnkd.in/eE-DmYif #HOB #bioclia #launchdiagnostics #autoimmune #Immunology

World Thrombosis Day, observed on October 13, raises awareness about the risks of blood clots (thrombosis) and their severe implications, such as stroke, heart attack, and deep vein thrombosis. It highlights the importance of early detection and prevention to reduce complications. Clonit’s PCR kits provide a complete coverage of frequent as well as rare mutations in genes related to the coagulation pathway reported to constitute risk factors for thrombophilia. For further information, please visit https://lnkd.in/eiD3SiC9 or contact your local Territory Manager. #worldthrombosisday #launchdiagnostics #clonit #cardiovasculardisease #thrombophilia

Third Party Serology controls may be used for day-to-day monitoring of assay performance and validations where sourcing clinical specimens is difficult, whilst simultaneously meeting regulatory requirements and increasing confidence in diagnostic results. The Immunocontrol range from Institut Virion Serion comprises over 25 controls which are compatible with a wide range of assays and technologies, and are lyophilised for convenience and stability. For further information follow the link below, or contact us at enquiries@launchdiagnostics.com https://lnkd.in/gDg-4cti

Today marks the beginning of the 24th #EUPERT meeting, bringing together experts from around Europe to discuss all things Pertussis. Launch Diagnostics are proud to sponsor this event, held at the beautiful #LondonDocklandsMuseum Hosted by #UKHSA we are excited to engage with delegates and to learn more about the work in this key field. #publichealth #diagnostics #pathology #infectiousdiseases #bordetellapertussis

The team at Launch Diagnostics are currently participating in a virtual exercise challenge to cover the distance from Lands End to John O’Groats. The challenge has fostered teamwork, encouraged physical activity, and boosted the teams’ mental wellbeing. Through working towards a shared goal, our team stay connected, energised, and engaged, enhancing productivity and creating a positive work environment, even remotely. Congratulations to our team for completing 40% of our goal so far! Trees are planted for each milestone within the challenge, creating a sense of shared accomplishment, with benefits for environmental sustainability. #endtoend #launchdiagnostics #wellbeing #sustainability

It’s Microbe time! The biggest and most exciting conference of the year! Come and meet the fabulous Launch team and ‘ABBA’ great time! With products encompassing #AMR #Molecular #Serology and much much more, come along to meet us and discuss your labs needs! #conference #microbe2024 #supportournhs #fancydress

Fungal diseases are a growing global threat; antimicrobial resistance is increasing and emerging fungal species are leading to more severe infections. There are no vaccines for fungal disease prevention, misdiagnosis is common, and there are only three classes of antifungal medications available for treatment. Join Launch for #FungalWeek24 as we raise awareness and work to improve fungal diagnostics. Launch Diagnostics provides comprehensive mycology testing solutions, including antifungal susceptibility testing from Liofilchem and serology testing for Aspergillus and Invasive Candidiasis, using the fully automated VirClia Lotus from Vircell. For more info, visit our website launchdiagnostics.com or email us at enquiries@launchdiagnostics.com . #FungalAwareness #HealthcareInnovation #InfectiousDiseases #AntifungalTesting #MycologyTesting #Innovation #Mycology #Antimicrobialresistance

Metric
Company Name	Launch Diagnostics
Symbol
MSH ID	COM:LAUNCHDIAGNOSTICS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	GB
Stage
Employee Count
Website	launchdiagnostics.com
LinkedIn	launch-diagnostics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

LAUN

COM:LAUNCHDIAGNOSTICS

Launch Diagnostics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue